NCT06909669Recruiting
Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders
Ultra-brief Psychological Treatments for Emocional Symptoms and Disorders: An Efficacy and Efficiency Analysis
Source: ClinicalTrials.gov · Last updated 2 Oct 2026
Brief summary (registry, in English)
The main objective of this randomized clinical trial is to study if various modalities of brief (eight sessions) and ultra-brief (four sessions) transdiagnostic cognitive-behavioral treatment work for decrease emotional symptoms and disorders, as well as to find out which emotional regulation processes and common factor of the intervention itself are involved in the therapeutic improvement. The investigators will compare the interventions of four groups: ultra-brief group treatment (1), brief group treatment (2), ultra-brief individual treatment (3) with the ultra-brief relaxation (control) group. The main questions the study aims to answer are: * Will the brief and ultra-brief treatment formats works better than the relaxation-based control group? * Will results obtained between the brief group therapy group and the ultra-brief group therapy group be similar? * Will the individual ultra brief therapy be more effective than the two group therapies because of common factors, such as the therapeutic alliance? * Will group therapies be more beneficial for cost and in terms of capability to reduce emocional symptoms than individual therapy? Participants will be randomly assigned to each of the groups and will receive the corresponding treatment, with different number of sessions. They will answer a series of questionnaires at the beginning and at the end of the intervention, as well as 3 months and 6 months after the end of the treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 184 (estimated)
- First submitted
- 7 Mar 2025
- Start date
- 28 Apr 2026
- Primary completion date
- Jun 2028
- Lead sponsor
- Universidad de Córdoba
- Diseases
- Depression
- NCT number
- NCT06909669
What you commit to
- Study type: Interventional
- Planned participants: 184
- From 28 Apr 2026 to the primary completion date, Jun 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Bipolar disorder, personality disorder, psychosis or substance abuse, indicated by SCID-5-CV
Other
- Recent suicide attempt.
- Severe emotional symptoms (PHQ-15 or GAD-7 ≥ 15; or PHQ-9 ≥ 20).
Who the study is looking for
- \- Patients presenting mild or moderate emotional symptomatology (anxiety, depression or somatizations). Specifically, they will be included in the study if they present a score ≥ 5 on the PHQ-9, the GAD-7 or the PHQ-15.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Unidad de Atención Psicológica (UNAP) de la Universidad de Córdoba Coordinator of this site? Confirm its status | Córdoba | Spain | Recruiting |
| Unidad de Salud Mental del Hospital Universitario Reina Sofía Coordinator of this site? Confirm its status | Córdoba | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.